Education
About Us
Working with TipRanks
Follow Us
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
CAPS Stock Chart & Stats
$0.91
$0.51(22.77%)
At close: 4:00 PM EST
$0.91
$0.51(22.77%)
Day’s Range― - ―
52-Week Range$0.73 - $16.18
Previous CloseN/A
Volume2.10K
Average Volume (3M)1.37M
Market Cap
$7.64M
Enterprise Value$29.73M
Total Cash (Recent Filing)$730.00K
Total Debt (Recent Filing)$23.25M
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Apr 07, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding7,906,205
10 Day Avg. Volume1,309,522
30 Day Avg. Volume1,370,765
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.12
Price to Sales (P/S)0.00787
P/FCF Ratio0.10
Enterprise Value/Market Cap3.89
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit3.04
Enterprise Value/Ebitda-10.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Capstone Therapeutics News
CAPS FAQ
What was Capstone Therapeutics Corp’s price range in the past 12 months?
Capstone Therapeutics Corp lowest stock price was $0.72 and its highest was $16.18 in the past 12 months.
What is Capstone Therapeutics Corp’s market cap?
Capstone Therapeutics Corp’s market cap is $7.64M.
When is Capstone Therapeutics Corp’s upcoming earnings report date?
Capstone Therapeutics Corp’s upcoming earnings report date is Apr 07, 2026 which is in 118 days.
How were Capstone Therapeutics Corp’s earnings last quarter?
Capstone Therapeutics Corp released its earnings results on Aug 19, 2025. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.06.
Is Capstone Therapeutics Corp overvalued?
According to Wall Street analysts Capstone Therapeutics Corp’s price is currently Overvalued.
Does Capstone Therapeutics Corp pay dividends?
Capstone Therapeutics Corp does not currently pay dividends.
What is Capstone Therapeutics Corp’s EPS estimate?
Capstone Therapeutics Corp’s EPS estimate is -0.14.
How many shares outstanding does Capstone Therapeutics Corp have?
Capstone Therapeutics Corp has 7,906,205 shares outstanding.
What happened to Capstone Therapeutics Corp’s price movement after its last earnings report?
Capstone Therapeutics Corp reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went down -4.386%.
Which hedge fund is a major shareholder of Capstone Therapeutics Corp?
Currently, no hedge funds are holding shares in CAPS
Company Description
Capstone Therapeutics Corp
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Technical Analysis
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.14% Other Institutional Investors
99.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---